The foundational Chronic Inflammatory Demyelinating Polyneuropathy Market Data highlights the impressive CAGR of 7.3% projected for the 2025–2035 forecast period. This strong statistical growth rate underscores the market's resilience, primarily due to the ongoing, essential need for chronic therapy and the high value attributed to effective treatments. Further key Chronic Inflammatory...